Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study

By D. Lloyd‐Jones, Martin G. Larson, E. Leip, A. Beiser, Ralph B. D’Agostino, W. Kannel, Joanne M. Murabito, Ramachandran S. Vasan, Emelia J. Benjamin, Daniel Levy. Circulation, 2002

1,655 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/b0c5ed4be937f30ee3cc1d82e9c19fda0762c935

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. G. Fonarow
2. Jimeng Sun
3. T. Horwich
4. J. Cleland
5. J. Januzzi
6. C. Yancy
7. M. Drazner
8. Véronique L. Roger

Citations in the corpus

• The Burden of Cardiovascular Disease in the Elderly: Morbidity, Mortality, and Costs (2009, background): “Incidence Older adults without HF have an approximately one in five lifetime risk for developing HF.(11) At 80 years of age, men without HF have a 20.”
• Limestone: High-throughput candidate phenotype generation via tensor factorization (2014, background): “Thus far, heart failure research has focused on epidemiology results, lifetime risk assessments from the Framingham study [73,74], predictions of hospital readmissions [75] or survival [76], and data-driven feature selection to complement known risk factors [77].”